
Miromatrix Medical Inc.
NASDAQ:MIRO
3.39 (USD) • At close December 12, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Miromatrix Medical Inc. |
Symbool | MIRO |
Munteenheid | USD |
Prijs | 3.39 |
Beurswaarde | 92,951,088 |
Dividendpercentage | 0% |
52-weken bereik | 0.906 - 4.35 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jeffrey James Ross Ph.D. |
Website | https://www.miromatrix.com |
An error occurred while fetching data.
Over Miromatrix Medical Inc.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)